[1] Zhu N, Zhang DY, Wang WL, Li XW, Yang B, Song JD, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382(8):727 − 33. http://dx.doi.org/10.1056/NEJMoa2001017CrossRef
[2] Di Gennaro F, Pizzol D, Marotta C, Antunes M, Racalbuto V, Veronese N, et al. Coronavirus diseases (COVID-19) current status and future perspectives: a narrative review. Int J Environ Res Public Health 2020;17(8):2690. http://dx.doi.org/10.3390/ijerph17082690CrossRef
[3] Rivett L, Sridhar S, Sparkes D, Routledge M, Jones NK, Forrest S, et al. Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission. eLife 2020;9:e58728. http://dx.doi.org/10.7554/eLife.58728CrossRef
[4] Gómez-Ochoa SA, Franco OH, Rojas LZ, Raguindin PF, Roa-Díaz ZM, Wyssmann BM, et al. COVID-19 in health-care workers: a living systematic review and meta-analysis of prevalence, risk factors, clinical characteristics, and outcomes. Am J Epidemiol 2021;190(1):161 − 75. http://dx.doi.org/10.1093/aje/kwaa191CrossRef
[5] Yang JM, Koh HY, Moon SY, Yoo IK, Ha EK, You S, et al. Allergic disorders and susceptibility to and severity of COVID-19: a nationwide cohort study. J Allergy Clin Immunol 2020;146(4):790 − 8. http://dx.doi.org/10.1016/j.jaci.2020.08.008CrossRef
[6] Palacios R, Patiño EG, de Oliveira Piorelli R, Conde M, Batista AP, Zeng G, et al. Double-blind, randomized, placebo-controlled phase Ⅲ clinical trial to evaluate the efficacy and safety of treating healthcare professionals with the adsorbed COVID-19 (inactivated) vaccine manufactured by sinovac - PROFISCOV: a structured summary of a study protocol for a randomised controlled trial. Trials 2020;21(1):853. http://dx.doi.org/10.1186/s13063-020-04775-4CrossRef
[7] Kashte S, Gulbake A, El-Amin Ⅲ SF, Gupta A. COVID-19 vaccines: rapid development, implications, challenges and future prospects. Hum Cell 2021;7:1 − 23. http://dx.doi.org/10.1007/s13577-021-00512-4CrossRef